11 employees
Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.
2022
$16M
from 3 investors over 3 rounds
Cocoon Bioscience raised $16M on March 14, 2023
Investors: North South Ventures, Cleon Capital Advisors and Viscofan